As Medicare physician reimbursement continues in 2025 to suffer from damaging shortfalls due to budget neutrality and lack of an inflation ...

VN: Our Cimas Health Group Dialysis Centre provides services to chronic and acute kidney failure patients and kidney ...

The guidance emphasizes important differences between AKI post-discharge and end-stage kidney disease; potential to recover ...

We came across a bullish thesis on Fresenius Medical Care AG (NYSE:FMS) on ValueInvestorsClub by mimval. In this article, we ...

Vantive, formerly the Baxter Kidney Care segment, has officially launched as an independent company dedicated to vital organ ...

Baxter reported Q4 adjusted EPS of $0.58, beating the $0.52 consensus and its own guidance of $0.50-$0.53. Baxter forecasts 2025 sales growth of 5%-6% and adjusted EPS of $2.45-$2.55, with Q1 2025 ...

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

Baxter generates most of its kidney care revenue from at-home patients using its peritoneal dialysis, or PD, tools, but it also sells hemodialysis products to dialysis clinics and continuous renal ...

As it repaired the plant, Baxter limited how much IV fluids customers could receive, and asked health care professionals to limit the number of new patients who could receive peritoneal dialysis.